Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
attached, bar, dropping, fraud, fraudulent, preempted, slight, statute, suspicion, unsuccessful, voluntary
Removed:
acceptance, Administration, Agency, ancillary, April, AXL, biologic, biological, biomarker, bispecific, bundled, cabozantinib, capturing, care, CDE, Center, cGMP, chance, clearance, Committee, connective, construct, credited, CTGF, customary, decoy, delayed, demonstrated, denied, dependence, designated, designation, disbursed, discovery, disease, documentation, dose, dosed, EMA, enter, exclusivity, expansion, factor, Fast, favorable, fluctuated, Food, goal, government, halted, halting, healthy, immune, implicated, Importantly, IND, initiated, initiating, initiation, Institute, international, Investigational, Junior, kinase, larger, launch, Leader, Leland, line, long, mainland, matched, matching, measuring, mechanism, medical, Medicinal, neutralizing, NMPA, objective, offset, orphan, participate, pathway, perform, pharmacodynamic, pharmacokinetic, pharmacologically, platinum, PMDA, preclinically, preliminary, produce, profile, programming, promoting, proof, proprietary, protecting, protein, randomized, reaching, receptor, recognizing, recommendation, recurrent, referenced, registrational, reimbursement, repay, resistance, resistant, responding, role, run, screen, securing, serum, signal, signaling, significance, sublicense, sublicensing, substitute, suppression, survive, symposium, tangible, targeting, technical, technology, temporarily, therapeutic, therapy, tissue, track, typically, tyrosine, updated, utilize, work, WuXi, yearly
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view